-
Journal menu
- General information
- Editorial Board and External Reviewers
- Journal Policies
- Publication Ethics and Malpractice Statement
- Instructions for authors
- Paper reviewing
- Article processing charge
- Feedback from stakeholders
- Journal’s Open Access statement
- Order hard copies of the journal
- 50 most cited papers in the journal
DO POISON PILLS INCREASE FIRM RISK?
Download This ArticleThomas A. Turk, Jeremy Goh, Candace E. Ybarra
Abstract
Management scholars have argued that an active takeover market discourages risk-taking by managers and that takeover defenses serve to counter the risk-reducing pressures of an active takeover market. This study employs the Black and Scholes Option Pricing Model to determine whether or not adoption of poison pill securities increases investor perceptions of firm risk. The results provide evidence that the Option-Implied Standard Deviations of common stock returns increase significantly on the poison pill adoption date, on average. Furthermore, the implied standard deviations remained significantly above pre-adoption levels for several days after the poison pill adoption, suggesting that the perceived increase in firm risk is permanent. These results suggest the poison pills may serve a more constructive role in the governance of publicly traded firms than is generally assumed.
Keywords: Acquisitions, Takeover Defenses, Firm Risk, Options, Management Incentives
How to cite this paper: Turk, T. A., Goh, J., & Ybarra, C. E. (2008). Do poison pills increase firm risk? Corporate Ownership & Control, 5(3), 47-53. https://doi.org/10.22495/cocv5i3p5
